PCSS Office-Based Treatment for Opioid Use Disorders Webinar - Monday, 4/25/2022

  • Registration Closed

This is PART 1 of the 8-hour waiver eligibility training.
NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582

Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course.

To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session.
Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT.

The presenter will be available to answer questions after the training has been completed.
Please submit all questions to pcssmat@aoaam.org. All questions will be answered within 4-7 days.


CONTINUING MEDICAL EDUCATION: This session has been approved for 4.25 AOA Category 1-A CME credits, providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources visit: www.pcssnow.org.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

William Morrone, DO, FAOAAM

Medical Director at Recovery Pathways

William Morrone, DO, MPH, DABAM, FACOFP & DAAPM, is Medical Director at Recovery Pathways, investigator in a naloxone distribution for Mid-Michigan, Medical Director of 35th Circuit Shiawassee County Drug Court, Associate Professor of Family and Community Medicine, Michigan State University for 18 years and was Program Director of Family Medicine at Synergy Medical Education Alliance and liaison in the Dept of Psychiatry. He is triple board certified by the American Board of Addiction Medicine, American College of Osteopathic Family Practitioners and the American Academy of Pain Management. Dr. Morrone was a Ruth Fox faculty for the 42nd ASAM 2011 Medical-Scientific Conference Washington DC and is an active addiction educator and social advocate in pain management. Dr. Morrone is Director of the Saginaw Chippewa Tribal Court & commissioner on the Governor’s Impaired Driving Commission 2017-2019; he is also Assistant Prof Johns Hopkins School of Nursing.

This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit.

CME certificates will be provided 30 days after the training date.

Key:

Complete
Failed
Available
Locked
PCSS Office-Based Treatment for Opioid Use Disorders Webinar - 4/25/2022
04/25/2022 at 8:00 PM (EDT)   |  300 minutes
04/25/2022 at 8:00 PM (EDT)   |  300 minutes This is PART 1 of the 8-hour waiver eligibility training. NOTE: This training has a starting time of 5:00 pm Pacific Time Zone. Please check your time zone for start time. Please download the Zoom app prior to training. https://zoom.us/ent?zcid=2582 Physicians are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. Those physicians who want to treat more than 30 patients at any one time, must take the 8-hour waiver course. To treat more than 30 patients, Advanced Practice Registered Nurses (APRN) (NP/CNM/CNS/CRNA) and Physician Assistants (PAs) must complete 24 hours of specialized training to prescribe buprenorphine. The training includes 8 hours of waiver training and an additional 16 hours of training. The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session. Instructions on how to log on to Part 2 of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please allow up to 48 hours to receive the email. It is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions and case studies in order for the AOAAM to verify your attendance. PHONE ONLY PARTICIPATION DOES NOT QUALIFY FOR PARTICIPATION CREDIT. Access to Part 2 will be emailed to you after successful participation of Part 1 is verified. Please note that this may take up to 48 hours. Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Certificate of Attendance
No credits available  |  Certificate available
No credits available  |  Certificate available This certificate certifies that you have successfully completed Part 1 of the training and have earned 4.25-hours of attendance credit to be applied towards the total required training of 8-hours. You are eligible to advance to Part 2 for the remaining 3.75-hours of training. A follow-up email will be sent to you within 48 hours of the training date with the link and directions on how to access Part 2. If you wish to receive CME credits for the training, please complete the remaining components of Part 1 which include a survey and post-webinar quiz.
OBOT Survey / 4.25-Hour
10 Questions
10 Questions As a CME accredited sponsor, it is required that an evaluation be provided to you in order to be compliant with CME regulations. Once you complete the survey, a certificate will be available for download/print.
Certificate of Attendance and CME
Up to 4.25 medical credits available  |  Certificate available
Up to 4.25 medical credits available  |  Certificate available The Certificate of Attendance and CME is your combined certificate verifying the training hours from Part 1, along with your CME credits earned. The Certificate of Attendance and CME verifies that the specified hours of training were completed and can be applied toward obtaining the waiver in the office-based treatment of opioid use disorders. Furthermore, please use this certificate to report CME to your respective accrediting board. If you are a D.O., the AOAAM will report your CME credits to the AOA for you. Please allow 90 days for the AOAAM to complete this process.